HMGB1 mediates homocysteine-induced endothelial cells pyroptosis via cathepsin V-dependent pathway

Yiping Leng1, Ruifang Chen2, Runtai Chen2

  • 1The Center for Vascular Disease and Translational Medicine, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China; Postdoctoral Station of Clinical Medicine, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.

Insights

High homocysteine (HHcy) triggers vascular inflammation and endothelial cell pyroptosis. High-mobility group box-1 (HMGB1) protein and cathepsin V mediate this process, offering new therapeutic targets for HHcy-associated vascular disease.

Area of Science:

  • Vascular Biology
  • Cell Death Mechanisms
  • Molecular Medicine

Background:

  • Hyperhomocysteinemia (HHcy) is linked to vascular inflammation, involving endothelial cell injury and pro-inflammatory cytokine release.
  • Pyroptosis, a programmed cell death pathway, releases IL-1β and involves gasdermin cleavage, but its role in HHcy-induced vascular issues is unclear.
  • Previous work implicated high-mobility group box-1 (HMGB1) and cathepsin V in HHcy-induced endothelial inflammation.

Purpose of the Study:

  • To investigate the role of HMGB1 and cathepsin V in homocysteine (Hcy)-induced endothelial cell pyroptosis.
  • To elucidate the underlying molecular mechanisms linking Hcy, HMGB1, cathepsin V, and pyroptosis in vascular inflammation.

Main Methods:

  • Assessed plasma IL-1β levels in HHcy patients and mouse models.
  • Utilized cathepsin V inhibitors in HHcy mice to evaluate effects on IL-1β and GSDMD cleavage.
  • Employed cultured human umbilical vein endothelial cells (HUVECs) to study Hcy effects, including gene silencing of GSDMD and HMGB1, and assessed lysosome permeability and caspase-1 activation.

Main Results:

  • HHcy patients and mice exhibited elevated plasma IL-1β.
  • Cathepsin V inhibition reduced IL-1β and GSDMD cleavage in HHcy mice.
  • Hcy promoted GSDMD N-terminal expression in HUVECs; silencing GSDMD or HMGB1 mitigated pyroptosis.
  • HMGB1 increased GSDMD N-terminal expression and lysosome permeability; cathepsin V silencing reversed HMGB1-induced pyroptosis and caspase-1 activation.

Conclusions:

  • HMGB1 mediates Hcy-induced endothelial cell pyroptosis through a pathway involving cathepsin V.
  • This study reveals a novel HMGB1-cathepsin V-dependent mechanism in HHcy-associated vascular inflammation.
  • Targeting HMGB1 and cathepsin V may offer therapeutic strategies for hyperhomocysteinemia-related vascular diseases.